US EPA

3039551 

Journal Article 

Dermal penetration of propylene glycols: Measured absorption across human abdominal skin in vitro and comparison with a QSAR model 

Fasano, WJ; ten Berge, W; Banton, MI; Heneweer, M; Moore, NP 

2011 

1 

Toxicology In Vitro
ISSN: 0887-2333
EISSN: 1879-3177 

25 

8 

1664-1670 

English 

21782927 

10.1016/j.tiv.2011.07.003 

WOS:000298362500019 

The dermal penetration of undiluted monopropylene glycol (MPG) and dipropylene glycol (DPG) has been measured in vitro using human abdominal skin under conditions of infinite dose application, and the results compared with predictions from the SKINPERM QSAR model (ten Berge, 2009). The measured steady-state penetration rates (J(ss)) for MPG and DPG were 97.6 and 39.3 mu g/cm(2)/h, respectively, and the permeability coefficients (K(p)) were 9.48 x 10(-5) cm/h for MPG and 3.85 x 10(-5) cm/h for DPG. In comparison, the SKINPERM model slightly over-predicted J(ss) and K(p) for MPG and DPG by between 2.6- and 5.1-fold, respectively. The model predictions of 254 mu g/cm(2)/h and 24.6 x 10(-5) cm/h for MPG, and 202 mu g/cm(2)/h and 19.8 x 10(-5) cm/h for DPG were in fairly good agreement with the measured values. Further, the model predicted a J(ss) of 101 mu g/cm(2)/h and a Kp of 9.9 x 10(-5) cm/h for the homologue tripropylene glycol. Assuming that the measured J(ss) was the same under conditions of finite dose application (taken to be 10 mu L/cm(2)) and was maintained over a 24-h period (both conservative assumptions), the relative dermal absorption of the applied dose was estimated to be 23% (0.96%/h) for MPG and 9% (0.39%/h) for DPG. However, the extrapolation for MPG may be further overestimated due to possible residence in the stratum corneum under infinite conditions of exposure that would not be applicable to a finite loading dose. (C) 2011 Elsevier Ltd. All rights reserved. 

Monopropylene glycol; Dipropylene glycol; Tripropylene glycol; Skin absorption; SKINPERM; In vitro